Penumbra
PEN
#1771
Rank
NZ$16.29 B
Marketcap
$424.67
Share price
-0.08%
Change (1 day)
3.18%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$0.66 Billion

According to Penumbra's latest financial reports the company's total liabilities are NZ$0.66 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.59 B1.83%
2022-12-31NZ$0.58 B38.22%
2021-12-31NZ$0.42 B64.63%
2020-12-31NZ$0.25 B-3.65%
2019-12-31NZ$0.26 B93.71%
2018-12-31NZ$0.13 B28.49%
2017-12-31NZ$0.10 B78.34%
2016-12-31NZ$60.21 M31.4%
2015-12-31NZ$45.82 M-73.12%
2014-12-31NZ$0.17 B76.78%
2013-12-31NZ$96.44 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$0.46 B-29.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.86 B 181.37%๐Ÿ‡บ๐Ÿ‡ธ USA